Elvucitabine
id:
elvucitabine-249-14036864
title:
Elvucitabine
text:
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Achillion Pharmaceuticals, Inc. for the treatment of HIV infection. Elvucitabine belongs to a class of HIV drugs called nucleoside reverse transcriptase inhibitors (NRTIs). By blocking reverse transcriptase enzymes, NRTIs prevent HIV from multiplying and can reduce the amount of HIV in the body. Elvucitabine is similar in chemical structure to the FDA-approved NRTIs lamivudine and emtricitabine. Howev
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Elvucitabine
date created:
date modified:
2023-12-17T09:54:32Z
main entity:
{"identifier":"Q1334337","url":"https://www.wikidata.org/entity/Q1334337"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/0/00/Elvucitabine_structure.svg","width":512,"height":454}
fields total:
13
integrity:
15